Related Experiment Video

Updated: Aug 15, 2026

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach
06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach

Published on: June 11, 2017

The ethical boundaries of drug research in pediatrics

M Rowell1, S Zlotkin

  • 1Department of Bioethics, Hospital for Sick Children, Toronto, Ontario, Canada.

Pediatric Clinics of North America
|February 1, 1997
PubMed

Insights

Children are often excluded from crucial drug research, leading to "therapeutic orphans." Expanding pediatric pharmacology research ethically is vital for ensuring safe and effective medications for children.

Area of Science:

  • Pediatric Pharmacology
  • Bioethics
  • Clinical Research

Background:

  • Children are frequently excluded from clinical drug research, resulting in a lack of evidence-based medication guidelines for pediatric populations.
  • Factors such as research abuses, regulatory hurdles, and professional misconceptions contribute to children becoming
  • therapeutic orphans.

Purpose of the Study:

  • To highlight the urgent moral imperative for expanding pediatric pharmacology research.
  • To emphasize the ethical considerations and potential risks involved in pediatric drug research.
  • To advocate for the protection and empowerment of children participating in clinical trials.

Main Methods:

  • This study is a review and ethical analysis of current practices in pediatric drug research.
  • It synthesizes existing literature on research abuses, regulatory frameworks, and professional attitudes.
  • It proposes an ethical framework for future pediatric research.

Main Results:

  • The current landscape of pediatric pharmacology research is characterized by underinvestment and ethical challenges.
  • Pediatricians have a critical role in advocating for both research expansion and child protection.
  • Ethical frameworks can ensure children's well-being and empowerment in research.

Conclusions:

  • Expanding pediatric pharmacology research is a moral necessity.
  • Ethical considerations must be paramount to protect children's rights and welfare.
  • A collaborative approach is essential to improve medication safety and efficacy for children.

Keywords:
Biomedical and Behavioral Research

More Related Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

Related Concept Videos

Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...